chloroquine has been researched along with Brain Vascular Disorders in 3 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| El Boussadani, B | 1 |
| Benajiba, C | 1 |
| Aajal, A | 1 |
| Ait Brik, A | 1 |
| Ammour, O | 1 |
| El Hangouch, J | 1 |
| Oussama, O | 1 |
| Oussama, B | 1 |
| Tahiri, N | 1 |
| Raissuni, Z | 1 |
| Reid, HA | 1 |
| Nkrumah, FK | 1 |
| Hill, GJ | 1 |
| Knight, V | 1 |
| Coatney, GR | 1 |
| Lawless, DK | 1 |
1 review available for chloroquine and Brain Vascular Disorders
| Article | Year |
|---|---|
[COVID-19 pandemia: Impact on the cariovascular system. Data of 1
Topics: Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Cardiomyopathies; Cardiovascular Dis | 2020 |
2 other studies available for chloroquine and Brain Vascular Disorders
| Article | Year |
|---|---|
Fibrin-degradation products in cerebral malaria.
Topics: Adolescent; Adult; Blood Coagulation Tests; Blood Platelets; Cerebrovascular Disorders; Child, Presc | 1972 |
Vivax malaria complicated by aphasia and hemiparesis.
Topics: Adult; Aphasia; Body Temperature; Cerebrovascular Disorders; Chloroquine; Hematocrit; Hemiplegia; Hu | 1963 |